
BiomX Raises $32 Million in Series B Financing
BiomX Ltd., a microbiome company developing customized phage therapies, announced the closing of a $32 million series B equity financing. The financing was led by existing investors OrbiMed, Johnson & Johnson Innovation – JJDC, Inc., […]